Nimotuzumab promotes radiosensitivity of EGFR-overexpression esophageal squamous cell carcinoma cells by upregulating IGFBP-3

BACKGROUND: Epidermal growth factor receptor (EGFR) is suggested to predict the radiosensitivity and/or prognosis of human esophageal squamous cell carcinoma (ESCC). The objective of this study was to investigate the efficacy of Nimotuzumab (an anti-EGFR monoclonal antibody) on ESCC radiotherapy (RT...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Lei, He, Li-Ru, Xi, Mian, Cai, Mu-Yan, Shen, Jing-Xian, Li, Qiao-Qiao, Liao, Yi-Ji, Qian, Dong, Feng, Zi-Zhen, Zeng, Yi-Xin, Xie, Dan, Liu, Meng-Zhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3540017/
https://www.ncbi.nlm.nih.gov/pubmed/23232108
http://dx.doi.org/10.1186/1479-5876-10-249

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3540017/
https://www.ncbi.nlm.nih.gov/pubmed/23232108
http://dx.doi.org/10.1186/1479-5876-10-249

Ejemplares similares